Corporate
2014.02.12
PAK01 selected as top 10% abstract by AHA
PAK01: A Synthesized Small Molecule That Enhances Reperfusion, Neuroprotection and Avoids Hemorrhagic Transformation in Rodent Models of Thromboembolic Stroke, a paper about LT-3001 presented at the 2014 International Stroke Conference, San Diego, USA, was selected as the top 10% abstracts, and invited to the Best of AHA Specialty Conference Poster Sessions on November 17, 2014, at McCormick Convention Center, Chicago, IL, USA. The International Stroke Conference, a premier scientific meeting organized by the American Heart Association, is the world s largest meeting for the basic, clinical and translational sciences and the treatments of cerebrovascular disease. More than 900 presentations of recent scientific work in cerebrovascular disease and stroke were introduced over a two and a half day conference.
Abstract
Abstract
